People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adela, Inc. | — | Biotechnology | Series C | $108.5M | $156.3M | 2021 |
Alan Williams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Williams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Weisskoff | 1 | 12 |
| Paul Brown | 1 | 12 |
| Andrew ElBardissi | 1 | 7 |
| David Scheer | 1 | 6 |
| David Bonita | 1 | 6 |
| Maneesh Jain | 1 | 2 |
| Lisa Alderson | 1 | 2 |
| Daniel Diniz De Carvalho | 1 | 1 |
| Priscilla Huang | 1 | 1 |
| Anne-Renee Hartman | 1 | 1 |
| Scott Bratman | 1 | 1 |
| Christopher Parker | 1 | 1 |
| Anne-Renee Hartman Feldman | 1 | 1 |
| Karla Jarvis | 1 | 1 |
| Daniel De Carvalho | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.